CME Group (CME) shares were down more than 2% in recent trading Monday after multiple analyst actions.
Citigroup downgraded the stock to neutral from buy and slashed its price target to $250 from $255. Meanwhile, Goldman Sachs cut its price target to $221 from $230 and kept its sell rating.
Trading volume stood at 1.4 million shares versus the daily average of 1.9 million shares.
Price: 227.38, Change: -5.13, Percent Change: -2.20
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.